Bahram Valamehr

CIK: 0001748177

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (71.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FATE

FATE THERAPEUTICS INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

FATE
FATE THERAPEUTICS INC
Aug 4, 2026
Sale(S)
Direct
43.9K shares at avg. $2.46$108K
FATE
FATE THERAPEUTICS INC
May 20, 2026
Sale(S)
Direct
28.9K shares at avg. $1.88$54K
FATE
FATE THERAPEUTICS INC
Jan 15, 2026
Award(A)
Direct
335K shares-
FATE
FATE THERAPEUTICS INC
Jan 9, 2026
Sale(S)
Direct
5.2K shares at avg. $1.07$6K
FATE
FATE THERAPEUTICS INC
Aug 4, 2025
Sale(S)
Direct
14.5K shares at avg. $1.06$15K
FATE
FATE THERAPEUTICS INC
Jan 16, 2025
Award(A)
Stock Option (Right to Buy)
Direct
1.3M shares-
FATE
FATE THERAPEUTICS INC
Jan 10, 2025
Sale(S)
Direct
8.7K shares at avg. $1.54$13K

		Type	Shares	Price		Ownership
Aug 4, 2026	FATE FATE THERAPEUTICS INC	Sale(S)	43,947	$2.46	$108,101	Direct
May 20, 2026	FATE FATE THERAPEUTICS INC	Sale(S)	28,946	$1.88	$54,482	Direct
Jan 15, 2026	FATE FATE THERAPEUTICS INC	Award(A)	335,000	-	$0	Direct
Jan 9, 2026	FATE FATE THERAPEUTICS INC	Sale(S)	5,190	$1.07	$5,557	Direct
Aug 4, 2025	FATE FATE THERAPEUTICS INC	Sale(S)	14,466	$1.06	$15,396	Direct
Jan 16, 2025	FATE FATE THERAPEUTICS INC	Award(A) Stock Option (Right to Buy)	1,300,000	-	-	Direct
Jan 10, 2025	FATE FATE THERAPEUTICS INC	Sale(S)	8,705	$1.54	$13,406	Direct

1-7 of 7 transactions

About Valamehr Bahram

Valamehr Bahram (SEC CIK 0001748177) files insider reports with the SEC as President and CEO of FATE THERAPEUTICS INC (FATE).

Signal8 holds 7 ownership filings by Valamehr Bahram, all Form 4s, filed between Jan 13, 2025 and Aug 5, 2026. Those filings report 7 transactions, from Jan 10, 2025 to Aug 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Valamehr Bahram's filings is in SAN DIEGO, CA.

Recent filings by Valamehr Bahram

Aug 4, 2026: Open-market sale of FATE shares (Form 4, code S).
May 20, 2026: Open-market sale of FATE shares (Form 4, code S).
Jan 15, 2026: Grant or award of FATE shares (Form 4, code A).
Jan 9, 2026: Open-market sale of FATE shares (Form 4, code S).
Aug 4, 2025: Open-market sale of FATE shares (Form 4, code S).

Other insiders filing for FATE THERAPEUTICS INC (FATE)

TAHL CINDY
Redmile Group, LLC, Director
Lee Michael Stewart, Director
Xu Yuan, Director
Jooss Karin, Director
EPSTEIN ROBERT S, Director

How to read Form 4 transaction codes